bpc-157 human clinical trial case report Wellness clinics promote the use of for recovery from injury or surgery. What do we know about it? It is effective in rodent models. Why might you think twice before using The Hidden Risks of BPC‑157:

General Safety Profile Based on the preclinical dataset and the limited human exposure data: No prominent signal of hepatic, renal, or hematological toxicity at tested doses No prominent cardiovascular safety flag Pregnancy and lactation as with most research compounds, safety not established Long-term effects not characterized What Clinicians Should Actually Tell Patients For patients asking about 5-amino-1MQ, a reasonable response framework: What the compound is: A research-stage small molecule inhibiting NNMT with promising preclinical fat loss data

Hydration affects tissue pliability and nutrient delivery

By healing the gut lining and decreasing inflammation, the peptide provides a protective layer against drug-induced damage, thus improving the bodys resilience to the negative effects of some pharmaceuticals

Possible side effects may include injection site redness, mild tenderness, temporary headache, fatigue, nausea, or localized irritation

doi: 10.1056/NEJMra1204699